The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines

Sara E. Monaco, James M Angelastro, Matthias Szabolcs, Lloyd A. Greene

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

ATF5, a transcription factor important in differentiation, proliferation and survival, has been found to be highly expressed in neural progenitor cells and in certain tumors including glioblastomas (GBMs), but its expression in other normal and neoplastic tissues has not been extensively investigated. A tissue microarray immunostained for ATF5 showed diffuse nuclear expression (as defined by the presence in greater than 25% of cells) in 63% (117/186) of neoplastic samples, when compared to only 32% (20/62) in nonneoplastic tissues. When analyzed by histologic subtype, a significantly greater proportion of adenocarcinomas, transitional cell carcinomas, squamous cell carcinomas and metastatic carcinomas of various tissue origins had nuclear staining when compared to nonneoplastic tissues. There was no significant difference in ATF5 expression in renal cell carcinomas, lymphomas and seminomas, when compared to nonneoplastic tissues. An expanded series of nonarray breast resection specimens revealed a significantly greater proportion of ATF5 positivity in ductal and lobular carcinomas, when compared to normal breast tissue. Past work found that loss of ATF5 function triggers death of GBM cells, but not of normal activated astrocytes. Here, we observed that loss of ATF5 function caused significant apoptotic death of neoplastic breast cell lines, but not of nonneoplastic breast cell lines. Our data demonstrate elevated ATF5 expression in a wide variety of neoplasms and that interference with ATF5 function selectively triggers death of breast carcinoma cells. Such findings may have potential therapeutic application.

Original languageEnglish (US)
Pages (from-to)1883-1890
Number of pages8
JournalInternational Journal of Cancer
Volume120
Issue number9
DOIs
StatePublished - May 1 2007

Fingerprint

Breast
Transcription Factors
Carcinoma
Cell Line
Glioblastoma
Lobular Carcinoma
Ductal Carcinoma
Seminoma
Transitional Cell Carcinoma
Renal Cell Carcinoma
Astrocytes
Squamous Cell Carcinoma
Lymphoma
Neoplasms
Adenocarcinoma
Cell Death
Stem Cells
Staining and Labeling
Breast Neoplasms

Keywords

  • Apoptosis
  • ATF5
  • Breast cancer
  • Cancer
  • Cancer tissue microarray
  • Ductal carcinoma
  • Lobular carcinoma
  • Microarray

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines. / Monaco, Sara E.; Angelastro, James M; Szabolcs, Matthias; Greene, Lloyd A.

In: International Journal of Cancer, Vol. 120, No. 9, 01.05.2007, p. 1883-1890.

Research output: Contribution to journalArticle

@article{8755f034d4594046a3273374c886181a,
title = "The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines",
abstract = "ATF5, a transcription factor important in differentiation, proliferation and survival, has been found to be highly expressed in neural progenitor cells and in certain tumors including glioblastomas (GBMs), but its expression in other normal and neoplastic tissues has not been extensively investigated. A tissue microarray immunostained for ATF5 showed diffuse nuclear expression (as defined by the presence in greater than 25{\%} of cells) in 63{\%} (117/186) of neoplastic samples, when compared to only 32{\%} (20/62) in nonneoplastic tissues. When analyzed by histologic subtype, a significantly greater proportion of adenocarcinomas, transitional cell carcinomas, squamous cell carcinomas and metastatic carcinomas of various tissue origins had nuclear staining when compared to nonneoplastic tissues. There was no significant difference in ATF5 expression in renal cell carcinomas, lymphomas and seminomas, when compared to nonneoplastic tissues. An expanded series of nonarray breast resection specimens revealed a significantly greater proportion of ATF5 positivity in ductal and lobular carcinomas, when compared to normal breast tissue. Past work found that loss of ATF5 function triggers death of GBM cells, but not of normal activated astrocytes. Here, we observed that loss of ATF5 function caused significant apoptotic death of neoplastic breast cell lines, but not of nonneoplastic breast cell lines. Our data demonstrate elevated ATF5 expression in a wide variety of neoplasms and that interference with ATF5 function selectively triggers death of breast carcinoma cells. Such findings may have potential therapeutic application.",
keywords = "Apoptosis, ATF5, Breast cancer, Cancer, Cancer tissue microarray, Ductal carcinoma, Lobular carcinoma, Microarray",
author = "Monaco, {Sara E.} and Angelastro, {James M} and Matthias Szabolcs and Greene, {Lloyd A.}",
year = "2007",
month = "5",
day = "1",
doi = "10.1002/ijc.22469",
language = "English (US)",
volume = "120",
pages = "1883--1890",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "9",

}

TY - JOUR

T1 - The transcription factor ATF5 is widely expressed in carcinomas, and interference with its function selectively kills neoplastic, but not nontransformed, breast cell lines

AU - Monaco, Sara E.

AU - Angelastro, James M

AU - Szabolcs, Matthias

AU - Greene, Lloyd A.

PY - 2007/5/1

Y1 - 2007/5/1

N2 - ATF5, a transcription factor important in differentiation, proliferation and survival, has been found to be highly expressed in neural progenitor cells and in certain tumors including glioblastomas (GBMs), but its expression in other normal and neoplastic tissues has not been extensively investigated. A tissue microarray immunostained for ATF5 showed diffuse nuclear expression (as defined by the presence in greater than 25% of cells) in 63% (117/186) of neoplastic samples, when compared to only 32% (20/62) in nonneoplastic tissues. When analyzed by histologic subtype, a significantly greater proportion of adenocarcinomas, transitional cell carcinomas, squamous cell carcinomas and metastatic carcinomas of various tissue origins had nuclear staining when compared to nonneoplastic tissues. There was no significant difference in ATF5 expression in renal cell carcinomas, lymphomas and seminomas, when compared to nonneoplastic tissues. An expanded series of nonarray breast resection specimens revealed a significantly greater proportion of ATF5 positivity in ductal and lobular carcinomas, when compared to normal breast tissue. Past work found that loss of ATF5 function triggers death of GBM cells, but not of normal activated astrocytes. Here, we observed that loss of ATF5 function caused significant apoptotic death of neoplastic breast cell lines, but not of nonneoplastic breast cell lines. Our data demonstrate elevated ATF5 expression in a wide variety of neoplasms and that interference with ATF5 function selectively triggers death of breast carcinoma cells. Such findings may have potential therapeutic application.

AB - ATF5, a transcription factor important in differentiation, proliferation and survival, has been found to be highly expressed in neural progenitor cells and in certain tumors including glioblastomas (GBMs), but its expression in other normal and neoplastic tissues has not been extensively investigated. A tissue microarray immunostained for ATF5 showed diffuse nuclear expression (as defined by the presence in greater than 25% of cells) in 63% (117/186) of neoplastic samples, when compared to only 32% (20/62) in nonneoplastic tissues. When analyzed by histologic subtype, a significantly greater proportion of adenocarcinomas, transitional cell carcinomas, squamous cell carcinomas and metastatic carcinomas of various tissue origins had nuclear staining when compared to nonneoplastic tissues. There was no significant difference in ATF5 expression in renal cell carcinomas, lymphomas and seminomas, when compared to nonneoplastic tissues. An expanded series of nonarray breast resection specimens revealed a significantly greater proportion of ATF5 positivity in ductal and lobular carcinomas, when compared to normal breast tissue. Past work found that loss of ATF5 function triggers death of GBM cells, but not of normal activated astrocytes. Here, we observed that loss of ATF5 function caused significant apoptotic death of neoplastic breast cell lines, but not of nonneoplastic breast cell lines. Our data demonstrate elevated ATF5 expression in a wide variety of neoplasms and that interference with ATF5 function selectively triggers death of breast carcinoma cells. Such findings may have potential therapeutic application.

KW - Apoptosis

KW - ATF5

KW - Breast cancer

KW - Cancer

KW - Cancer tissue microarray

KW - Ductal carcinoma

KW - Lobular carcinoma

KW - Microarray

UR - http://www.scopus.com/inward/record.url?scp=33947232832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947232832&partnerID=8YFLogxK

U2 - 10.1002/ijc.22469

DO - 10.1002/ijc.22469

M3 - Article

VL - 120

SP - 1883

EP - 1890

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 9

ER -